ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Yumanity Therapeutics signs drug development deal with Merck
June 28, 2020US-based Yumanity Therapeutics has signed a research collaboration and licence agreement with Merck (MSD) to develop new therapies for neurodegenerative diseases. -
Sangamo and Pfizer announce collaboration
November 19, 2018Currently, there are no cures to halt or reverse the progression of ALS or FTLD. The C9ORF72 mutation is linked to approximately one-third of cases of familial ALS
Pharma Sources Insight January 2025
